{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T05:07:14Z","timestamp":1777698434044,"version":"3.51.4"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1998,8]]},"DOI":"10.1212\/wnl.51.2.609","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:35:18Z","timestamp":1336916118000},"page":"609-611","source":"Crossref","is-referenced-by-count":90,"title":["An open-lebel trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients"],"prefix":"10.1212","volume":"51","author":[{"given":"C.","family":"Solaro","sequence":"first","affiliation":[{"name":"From the Department of Neurological Sciences and Neurorehabilitation University of Genoa (Drs. Solaro, Lunardi, Capello, Messmer Uccelli, Uccelli, and Mancardi); and the Italian Multiple Sclerosis Society, Department of Social and Health Services and Research (Dr. Inglese), Genoa, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. L.","family":"Lunardi","sequence":"additional","affiliation":[{"name":"From the Department of Neurological Sciences and Neurorehabilitation University of Genoa (Drs. Solaro, Lunardi, Capello, Messmer Uccelli, Uccelli, and Mancardi); and the Italian Multiple Sclerosis Society, Department of Social and Health Services and Research (Dr. Inglese), Genoa, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Capello","sequence":"additional","affiliation":[{"name":"From the Department of Neurological Sciences and Neurorehabilitation University of Genoa (Drs. Solaro, Lunardi, Capello, Messmer Uccelli, Uccelli, and Mancardi); and the Italian Multiple Sclerosis Society, Department of Social and Health Services and Research (Dr. Inglese), Genoa, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Inglese","sequence":"additional","affiliation":[{"name":"From the Department of Neurological Sciences and Neurorehabilitation University of Genoa (Drs. Solaro, Lunardi, Capello, Messmer Uccelli, Uccelli, and Mancardi); and the Italian Multiple Sclerosis Society, Department of Social and Health Services and Research (Dr. Inglese), Genoa, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Messmer M.","family":"Uccelli","sequence":"additional","affiliation":[{"name":"From the Department of Neurological Sciences and Neurorehabilitation University of Genoa (Drs. Solaro, Lunardi, Capello, Messmer Uccelli, Uccelli, and Mancardi); and the Italian Multiple Sclerosis Society, Department of Social and Health Services and Research (Dr. Inglese), Genoa, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Uccelli","sequence":"additional","affiliation":[{"name":"From the Department of Neurological Sciences and Neurorehabilitation University of Genoa (Drs. Solaro, Lunardi, Capello, Messmer Uccelli, Uccelli, and Mancardi); and the Italian Multiple Sclerosis Society, Department of Social and Health Services and Research (Dr. Inglese), Genoa, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. L.","family":"Mancardi","sequence":"additional","affiliation":[{"name":"From the Department of Neurological Sciences and Neurorehabilitation University of Genoa (Drs. Solaro, Lunardi, Capello, Messmer Uccelli, Uccelli, and Mancardi); and the Italian Multiple Sclerosis Society, Department of Social and Health Services and Research (Dr. Inglese), Genoa, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","unstructured":"Schapiro RT Baumhefner RW Tourtellotte WW. Multiple sclerosis: a clinical viewpoint to management. In: Raine CS McFarland HF Tourtellotte WW eds. Multiple sclerosis: clinical and pathogenetic basis. London: Chapman & Hall 1997: 391-420."},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90873-7"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.1.1"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410410105"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-9993(97)90149-0"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.49.5_Suppl_4.S3"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.49.1.1"},{"key":"e_1_3_1_9_2","first-page":"2","volume":"43","year":"1993","unstructured":"The US Gabapentin Study Group No. 5 Gabapentin as add-on therapy in refractory partial epilepsy: A double-blind, placebo-controlled, parallel-group study. Neurology 1993;43:2292-2297.","journal-title":"Neurology"},{"key":"e_1_3_1_10_2","unstructured":"McLean MJ. Clinical pharmacokinetics of gabapentin. Neurology 1994;44(suppl 5):S17-S22."},{"key":"e_1_3_1_11_2","unstructured":"Taylor CP. Emerging perspectives on the mechanism of action of gabapentin. Neurology 1994;44(suppl 5):S10-S16."}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.51.2.609","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T15:01:49Z","timestamp":1711551709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.51.2.609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,8]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,8]]}},"alternative-id":["10.1212\/WNL.51.2.609"],"URL":"https:\/\/doi.org\/10.1212\/wnl.51.2.609","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,8]]}}}